Nearly One Year Post-Launch Biogen & Coherus Biosciences’ Ranibizumab…
Exton, Pennsylvania, June 23, 2023 (GLOBE NEWSWIRE) -- Spherix has been tracking ophthalmologists’ attitudes and perceptions around biosimilars in their Special Topix: Ophthalmology…